Search

everythinglearnresearchcommunity

for

Search:↓

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Women with PCOS may be more likely to have gum disease than healthy women.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.